IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
154.73
+0.12 (0.08%)
At close: Jun 20, 2025, 4:00 PM
155.04
+0.31 (0.20%)
After-hours: Jun 20, 2025, 7:59 PM EDT
IQVIA Holdings Market Cap
IQVIA Holdings has a market cap or net worth of $26.77 billion as of June 20, 2025. Its market cap has decreased by -32.13% in one year.
Market Cap
26.77B
Enterprise Value
39.43B
1-Year Change
-32.13%
Ranking
Category
Stock Price
$154.73
Market Cap Chart
Since May 9, 2013, IQVIA Holdings's market cap has increased from $5.46B to $26.77B, an increase of 390.47%. That is a compound annual growth rate of 14.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 18, 2025 | 26.75B | -25.01% |
Dec 31, 2024 | 35.67B | -15.54% |
Dec 29, 2023 | 42.23B | 10.96% |
Dec 30, 2022 | 38.06B | -29.39% |
Dec 31, 2021 | 53.90B | 56.91% |
Dec 31, 2020 | 34.35B | 14.58% |
Dec 31, 2019 | 29.98B | 27.57% |
Dec 31, 2018 | 23.50B | 13.60% |
Dec 29, 2017 | 20.69B | 10.50% |
Dec 30, 2016 | 18.72B | 121.52% |
Dec 31, 2015 | 8.45B | 12.33% |
Dec 31, 2014 | 7.52B | 25.93% |
Dec 31, 2013 | 5.97B | 9.47% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 685.48B |
Johnson & Johnson | 359.83B |
Novo Nordisk | 333.14B |
AbbVie | 326.11B |
UnitedHealth Group | 276.47B |
Abbott Laboratories | 230.98B |
Novartis AG | 227.73B |
AstraZeneca | 219.65B |